Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

TO: Interested Parties 

FROM: Planned Parenthood Federation of America & Planned Parenthood Action Fund

DATE: February 23, 2023

RE: State of medication abortion access across the country 


Last year, a group of anti-abortion activists and organizations filed suit challenging the FDA over its approval of mifepristone, one of two medications most commonly used in medication abortion in the United States. In the coming weeks, a Texas judge is expected to issue a ruling in the case, Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al, which could force the FDA to rescind its approval of mifepristone from more than 20 years ago and remove it from the market. 

This would result in a devastating nationwide ban on mifepristone — even in states where abortion is protected — and compromise access to medication abortion across the country. Medication abortion accounts for more than half of all abortions in the United States. 

But no matter the judge’s ruling, access to medication abortion has already been severely limited. Not satisfied with the overturning of Roe v. Wade, state lawmakers opposed to abortion, including those in the states where abortion is fully banned, have continued their attacks on medication abortion during the 2023 state legislative session. 

Right now, bans have eliminated some or all access to both procedural and medication abortion in 18 states: Alabama, Arkansas, Arizona, Florida, Georgia, Idaho, Kentucky, Louisiana, Missouri, Mississippi, North Carolina, Oklahoma, South Dakota, Tennessee, Texas, Utah, Wisconsin, and West Virginia. In addition to these 18 states that have broad abortion bans in place, four more states have laws that specifically limit the provision of medication abortion via telemedicine, including Indiana, Nebraska, North Dakota, and South Carolina. States with access to abortion, and those that have banned abortion, are responding in a number of ways that will shape the medication abortion access landscape regardless of the forthcoming decision. 

So far this session, 10 states have introduced bills restricting access to medication abortion — many in states where abortion is already fully banned. 

  • Iowa: State politicians introduced a ban on medication abortion, which accounts for 79% of abortions in Iowa. The proposed ban would make it a felony to manufacture, distribute, prescribe, dispense, sell, or transfer medication abortion pills in the state with penalties of up to 10 years in prison or a fine of up to $13,660. Abortion is currently still legal in Iowa.
  • Wyoming: Lawmakers are considering a bill to criminalize the manufacturing, distribution, or prescribing of medication abortion — including misoprostol, which is also used for non-abortion care, including miscarriage management. There is also a penalty for providers who violate the ban. 
  • Missouri: Legislation to ban the export, delivery, manufacture, and prescription of medication abortion has been introduced. This bill would also ban wholesale drug distributors from delivering medication abortion directly to patients. The legislation would also define “trafficking” medication abortion pills as a Class B felony and prohibit state pharmacists from delivering these pills to patients via mail.
  • Texas: A bill that would allow pharmacists to refuse to dispense abortifacients or emergency contraceptives is under consideration. 
  • West Virginia: Several bills attacking medication abortion have been introduced, including legislation to prohibit mail order pharmacies from dispensing abortion pills and a bill to fine providers who attempt to provide medication abortion via telemedicine. 
  • Colorado, New Hampshire, and West Virginia: Bills that would require providers to share medically inaccurate information on medication abortion “reversal” have been introduced in each state.

On the proactive front, California lawmakers introduced legislation to ensure continued  Medi-Cal coverage for abortion medication by updating coverage requirements to align with the  most up-to-date clinical guidelines. In New York and Connecticut, lawmakers are considering legislation to direct health centers on college and university campuses to make medication abortion available onsite. And in Indiana, a bill to repeal the gestational age limit on medication abortions has been introduced.

If you plan to cover medication abortion restriction moving at the state level or the current federal case that could result in a ban on mifepristone, please reach out to [email protected]


This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.



We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.



We use qualitative data, including session replay, to learn about your user experience and improve our products and services.



We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.